Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

JNJ PFE NVS SNY Chemicals Large Value Aluminum Moderate 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Processing. Please wait...

Raptor Market Capitalization

 
 Companies |  Insiders  | Dashboard  
     
Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Raptor

Market Cap

=

Shares Outstanding

X

Share Price

=
420.72 M
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Compare Raptor to competition

Raptor Market Capitalization Assessment

Based on recorded statements the market capitalization of Raptor Pharmaceuticals Corp is about 420.72 M. This is 97.03% lower than that of Healthcare sector, and 99.57% lower than that of Drug Manufacturers - Major industry, The Market Capitalization for all stocks is 96.27% higher than the company.

Filter other Stocks by Market Capitalization

Specify Market Cap
Select Market Capitalization Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Raptor Pharmaceuticals Corp is rated below average in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Major industry is at this time estimated at about 1.25 Trillion. Raptor adds roughly 420.72 Million in market capitalization claiming only tiny portion of equities under Drug Manufacturers - Major industry.
Follow Raptor Market Capitalization with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Raptor to your reader
 
    
RPTP United States Nasdaq
Raptor Pharmaceuticals Corp
Benchmark S&P 500
Currency: USD - US Dollar
Traded on NASDAQ General Markets
    
    

Other Raptor Fundamentals

Return On Equity(145.22) %
Return On Asset(48.27) %
Current Valuation335.23 M
Shares Outstanding55.43 M
Shares Owned by Insiders3.13 %
Shares Owned by Institutions39.80 %
Number of Shares Shorted8.14 M
Price to Earning115.60 times
Price to Book17.84 times
EBITDA(43.46 M)
Net Income(41.84 M)
Cash and Equivalents58.41 M
Cash per Share1.05 times
Total Debt25.02 M
Debt to Equity1.08 times
Current Ratio2.60 times
Book Value Per Share0.42 times
Cash Flow from Operations(34.68 M)
Short Ratio10.30 times
One Year High7.79
One Year Low4.35
Earnings Per Share(0.84) times
Number of Employees41
Beta0.12
Market Capitalization420.72 M
Total Asset44.48 M
Retained Earnings(130.04 M)
Working Capital17.26 M
Current Asset38.33 M
Current Liabilities21.07 M
Z Score6.8
Probability Of Bankruptcy9.00 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium